The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis. (Q51110611)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 November 2016

Language	Label	Description	Also known as
English	The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis.	scientific article published on 3 November 2016

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Ahmad Zarejavid

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Ahmad Zare Javid

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Razie Hormoznejad

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Hojat Allah Yousefimanesh

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Mehrnoosh Zakerkish

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Mohammad Hosein Haghighi-Zadeh

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Parvin Dehghan

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Maryam Ravanbakhsh

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

3 November 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Phytotherapy Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

108-114

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Lipid peroxidation is associated with the severity of periodontal disease and local inflammatory markers in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol Pretreatment Affects CYP2E1 Activity of Chlorzoxazone in Healthy Human Volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Effect of Resveratrol Treatment on the Pharmacokinetics of Diclofenac in Healthy Human Volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Reactive oxygen species in periodontitis

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Diabetes and periodontal disease

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol and liver: A systematic review

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Leukocyte production of inflammatory mediators is inhibited by the antioxidants phloretin, silymarin, hesperetin, and resveratrol

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Global estimates of diabetes prevalence for 2013 and projections for 2035.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Non-surgical periodontal therapy affects metabolic control in diabetics: a randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Review of the Pharmacological Effects of Vitis vinifera (Grape) and its Bioactive Constituents: An Update

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Periodontal diseases: pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharide-induced endothelial adhesion molecule expression by suppressing NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Bidirectional association between diabetes mellitus and inflammatory periodontal disease. A review

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol, obesity and diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Periodontal disease: associations with diabetes, glycemic control and complications

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Efficacy of nonsurgical periodontal therapy on glycaemic control in type II diabetic patients: a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Relationship between metabolic syndrome and diagnoses of periodontal diseases among participants in a large Taiwanese cohort.

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Resveratrol and diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Diabetes mellitus related bone metabolism and periodontal disease

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Effects of Resveratrol on Receptor for Advanced Glycation End Products (RAGE) Expression and Oxidative Stress in the Liver of Rats with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FPTR.5737

21 January 2018

Identifiers

10.1002/PTR.5737

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27807887%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51110611&oldid=1538965875"